157 related articles for article (PubMed ID: 33914948)
1. Differential inflammatory responses associated with Leishmania major and L tropica in culture.
Darzi F; Davoudian R; Nateghi Rostami M
Parasite Immunol; 2021 Aug; 43(8):e12841. PubMed ID: 33914948
[TBL] [Abstract][Full Text] [Related]
2. Moroccan strains of Leishmania major and Leishmania tropica differentially impact on nitric oxide production by macrophages.
Maksouri H; Dang PM; Rodrigues V; Estaquier J; Riyad M; Akarid K
Parasit Vectors; 2017 Oct; 10(1):506. PubMed ID: 29061164
[TBL] [Abstract][Full Text] [Related]
3. Changes in the Epidemiology of Cutaneous Leishmaniasis in Northeastern Iran.
Farash BRH; Shamsian SAA; Mohajery M; Fata A; Sadabadi F; Berenji F; Mastroeni P; Poustchi E; Moghaddas E; Sangani GS; Farnoosh G
Turkiye Parazitol Derg; 2020 Mar; 44(1):52-57. PubMed ID: 32212595
[TBL] [Abstract][Full Text] [Related]
4. Host's immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: A case-control study of Th1 and Th2 pathways.
Bamorovat M; Sharifi I; Aflatoonian MR; Sadeghi B; Shafiian A; Oliaee RT; Keyhani A; Afshar AA; Khosravi A; Mostafavi M; Parizi MH; Khatami M; Arefinia N
Int Immunopharmacol; 2019 Apr; 69():321-327. PubMed ID: 30771740
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of localized and systemic immune responses in cutaneous leishmaniasis caused by Leishmania tropica: interleukin-8, monocyte chemotactic protein-1 and nitric oxide are major regulatory factors.
Kumar R; Bumb RA; Salotra P
Immunology; 2010 Jun; 130(2):193-201. PubMed ID: 20102417
[TBL] [Abstract][Full Text] [Related]
6. Immune response to Leishmania antigen in anthroponotic cutaneous leishmaniasis.
Ajdary S; Riazi-Rad F; Alimohammadian MH; Pakzad SR
J Infect; 2009 Aug; 59(2):139-43. PubMed ID: 19560211
[TBL] [Abstract][Full Text] [Related]
7. Analysis of localized immune responses reveals presence of Th17 and Treg cells in cutaneous leishmaniasis due to Leishmania tropica.
Katara GK; Raj A; Kumar R; Avishek K; Kaushal H; Ansari NA; Bumb RA; Salotra P
BMC Immunol; 2013 Nov; 14():52. PubMed ID: 24267152
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of TLRs 2, 4, 9, iNOS and TNF-α and arginase activity in peripheral blood monocytes from glucantime unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis caused by Leishmania tropica.
Oliaee RT; Sharifi I; Afgar A; Jafarzadeh A; Kareshk AT; Bamorovat M; Sharifi H; Babaei Z; Keyhani A; Keyhani A; Abedi L; Sharifi F
Microb Pathog; 2019 Jan; 126():368-378. PubMed ID: 30399441
[TBL] [Abstract][Full Text] [Related]
9. EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica.
El Hajj R; Bou Youness H; Lachaud L; Bastien P; Masquefa C; Bonnet PA; El Hajj H; Khalifeh I
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006854. PubMed ID: 30462645
[TBL] [Abstract][Full Text] [Related]
10. Cellular mediators in human leishmaniasis: Critical determinants in parasite killing or disease progression.
Divenuto F; Marascio N; Quirino A; Giancotti A; Filice S; Gigliotti S; Campolo MP; Campolo M; Barreca GS; Lamberti AG; Castelli G; Bruno F; Matera G
Acta Trop; 2023 Dec; 248():107037. PubMed ID: 37805040
[TBL] [Abstract][Full Text] [Related]
11. Leishmania cytochrome b gene sequence polymorphisms in southern Iran: relationships with different cutaneous clinical manifestations.
Mohammadpour I; Hatam GR; Handjani F; Bozorg-Ghalati F; PourKamal D; Motazedian MH
BMC Infect Dis; 2019 Jan; 19(1):98. PubMed ID: 30696426
[TBL] [Abstract][Full Text] [Related]
12. Comparing acute and chronic human cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica focusing on arginase activity.
Mortazavi H; Sadeghipour P; Taslimi Y; Habibzadeh S; Zali F; Zahedifard F; Rahmati J; Kamyab K; Ghandi N; Zamanian A; Reza Tohidinik H; Muller I; Kropf P; Rafati S
J Eur Acad Dermatol Venereol; 2016 Dec; 30(12):2118-2121. PubMed ID: 27439742
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of cutaneous leishmaniasis and heterogeneity of Leishmania major strains in Iran.
Mahmoudzadeh-Niknam H; Ajdary S; Riazi-Rad F; Mirzadegan E; Rezaeian A; Khaze V; Djadid ND; Alimohammadian MH
Trop Med Int Health; 2012 Nov; 17(11):1335-44. PubMed ID: 22947226
[TBL] [Abstract][Full Text] [Related]
14. Leishmania tropica: suggestive evidences for the effect of infectious dose on pathogenicity and immunogenicity in an experimental model.
Rostamian M; Jafari D; Abolghazi M; Farahani H; Niknam HM
Parasitol Res; 2018 Sep; 117(9):2949-2956. PubMed ID: 29978420
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcome of imported cutaneous leishmaniasis among travelers and migrants infected with Leishmania major and Leishmania tropica: a retrospective study in European centers 2013 to 2019.
Glans H; Dotevall L; Van der Auwera G; Bart A; Blum J; Buffet P; Guery R; Gangneux JP; van Henten S; Harms G; Varani S; Robert-Gangneux F; Rongisch R; Andersson B; Bradley M
Int J Infect Dis; 2022 Sep; 122():375-381. PubMed ID: 35728749
[TBL] [Abstract][Full Text] [Related]
16. TNF-α - 308 G/A and IFN-γ + 874 A/T gene polymorphisms in Saudi patients with cutaneous leishmaniasis.
Ahmed AA; Rasheed Z; Salem T; Al-Dhubaibi MS; Al Robaee AA; Alzolibani AA
BMC Med Genet; 2020 May; 21(1):104. PubMed ID: 32404058
[TBL] [Abstract][Full Text] [Related]
17. Molecular Characterization of
Alraey Y; Alhweti R; Almutairi H; Abdullah Al-Qahtani A; Alshahrani MI; Asiri MH; Alhammas AM; Alwagdi SJ; Alshahrani A; Alouffi A; Madkhali AM; Al-Salem WS; Al-Qahtani AA; Saif A; Ben Hadj Ahmed S; Zhioua E
Pathogens; 2022 Dec; 11(12):. PubMed ID: 36558806
[TBL] [Abstract][Full Text] [Related]
18. Identification of differential protein expression and putative drug target in metacyclic stage of Leishmania major and Leishmania tropica: A quantitative proteomics and computational view.
Amiri-Dashatan N; Ahmadi N; Rezaei-Tavirani M; Koushki M
Comp Immunol Microbiol Infect Dis; 2021 Apr; 75():101617. PubMed ID: 33581562
[TBL] [Abstract][Full Text] [Related]
19. Protective immunity against Leishmania major induced by Leishmania tropica infection of BALB/c mice.
Mahmoudzadeh-Niknam H; Kiaei SS; Iravani D
Exp Parasitol; 2011 Feb; 127(2):448-53. PubMed ID: 21035446
[TBL] [Abstract][Full Text] [Related]
20. Histological and immunological differences between zoonotic cutaneous leishmaniasis due to Leishmania major and sporadic cutaneous leishmaniasis due to Leishmania infantum.
Boussoffara T; Boubaker MS; Ben Ahmed M; Mokni M; Guizani I; Ben Salah A; Louzir H
Parasite; 2019; 26():9. PubMed ID: 30810524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
